Wall Street Journal examines efforts to encourage adoption of electronic prescribing technology

The Wall Street Journal on Tuesday examined several factors that are pushing physicians to adopt electronic prescribing technology, reporting that while the "possible benefits to doctors and patients are clear," there are obstacles that "hinder widespread adoption." Fewer than 10%, or about 35,000, of U.S. physicians currently use e-prescribing technology.

In an effort to encourage small and rural-based physicians and pharmacies to adopt the technology, private health insurers are providing financial incentives or assistance to offset costs. For example, WellPoint offers higher payments to physicians in Ohio and the Northeast who use e-prescribing, and Blue Cross Blue Shield of Massachusetts subsidizes e-prescribers' costs in the state for one year through the corporate coalition eRX Collaborative.

State and national programs are being established to help physicians with problems they could face during the transition phase, as well as costs.

In addition, the American Academy of Nurse Practitioners and the American Academy of Physician Assistants this week announced their support for Get Connected, a new program that provides clinical software evaluations and advice, the Journal reports. Computer programs also can alert physicians and pharmacies to low-cost, generic versions of costly medications that would be covered under the patient's health plan (Knight, Wall Street Journal, 6/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Transcranial ultrasound stimulation: A new frontier in noninvasive brain therapy